A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
Eli Lilly and Company
Pheast Therapeutics
Theolytics Limited
University of Colorado, Denver
NiKang Therapeutics, Inc.
Dana-Farber Cancer Institute
EMD Serono
Regor Pharmaceuticals Inc.
Kumquat Biosciences Inc.
Seagen Inc.
Seagen Inc.
Pliant Therapeutics, Inc.
Eli Lilly and Company
Oncoinvent Solutions AS
National Cancer Institute (NCI)
BioNTech SE
MOMA Therapeutics
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Instil Bio
Genentech, Inc.
M.D. Anderson Cancer Center
AstraZeneca
MOMA Therapeutics
Kestrel Therapeutics, Inc.
Chong Kun Dang Pharmaceutical
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Mersana Therapeutics
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Context Therapeutics Inc.